Manchester Capital Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-35
Closed -$1.52K 1090
2023
Q1
$1.52K Buy
35
+9
+35% +$397 ﹤0.01% 846
2022
Q4
$970 Buy
26
+22
+550% +$851 ﹤0.01% 822
2022
Q3
$0 Sell
4
-13
-76% -$481 ﹤0.01% 970
2022
Q2
$1K Buy
+17
New +$615 ﹤0.01% 858

Other funds holding NRC

Manchester Capital Management's NRC Position: Q2 2023 in Review

Manchester Capital Management sold out of NRC Health Common Stock (NRC) in Q2 2023, closing a stake of 35 shares — an estimated $1.52K sold.

Manchester Capital Management first reported a position in NRC in Q2 2022 and held it in 4 quarters. The position peaked at $1.52K in Q1 2023. 116 funds tracked by Wall St. Rank hold NRC as of Q2 2023.

  • Manchester Capital Management reported no remaining NRC Health Common Stock position as of Q2 2023 after selling out during the quarter.
  • Manchester Capital Management sold 35 NRC Health Common Stock shares in Q2 2023, an estimated $1.52K.
  • Manchester Capital Management first reported a position in NRC Health Common Stock in Q2 2022 and held it in 4 quarters.
  • Manchester Capital Management's NRC Health Common Stock position peaked at $1.52K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2023.

Based on Manchester Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.